GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
Author(s) -
Thea Anine Strøm Halden,
Erlend Johannessen Egeland,
Anders Åsberg,
Anders Hartmann,
Karsten Midtvedt,
Hassan Z. Khiabani,
Jens J. Holst,
Filip K. Knop,
Mads Hornum,
Bo FeldtRasmussen,
Trond Jenssen
Publication year - 2016
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc15-2383
Subject(s) - medicine , endocrinology , glucagon , insulin , diabetes mellitus , arginine , bolus (digestion) , proinsulin , pancreatic hormone , glucose clamp technique , hyperglucagonemia , incretin , clamp , type 2 diabetes , insulin resistance , biology , amino acid , biochemistry , mechanical engineering , clamping , engineering
Development of posttransplantation diabetes (PTDM) is characterized by reduced insulin secretion and sensitivity. We aimed to investigate whether hyperglucagonemia could play a role in PTDM and to examine the insulinotropic and glucagonostatic effects of the incretin hormone glucagon-like peptide 1 (GLP-1) during fasting and hyperglycemic conditions, respectively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom